Point72 Hong Kong LTD Arcturus Therapeutics Holdings Inc. Transaction History

Point72 Hong Kong LTD

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$12.26 - $31.17 $77,483 - $196,994	6,320 Added 3653.18%	6,493 $102,000
Q1 2022 May 16, 2022	BUY	$17.64 - $39.57 $3,051 - $6,845	173 New	173 $5,000
Q4 2021 Feb 14, 2022	SELL	$34.2 - $47.56 $82,832 - $115,190	-2,422 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$27.88 - $58.25 $67,525 - $141,081	2,422 New	2,422 $116,000
Q2 2021 Aug 16, 2021	SELL	$25.79 - $42.11 $11,889 - $19,412	-461 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$38.75 - $86.92 $17,863 - $40,070	461 New	461 $19,000
Q4 2020 Feb 16, 2021	SELL	$34.61 - $123.66 $78,945 - $282,068	-2,281 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$37.49 - $63.19 $84,952 - $143,188	2,266 Added 15106.67%	2,281 $98,000
Q2 2020 Aug 14, 2020	BUY	$12.66 - $58.27 $189 - $874	15 New	15 $1,000

179

25.6M

195K

133K

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $411M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.